Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Virtual Velocity

CMEA Capital launches Velocity, a virtual drug development company

Virtual Velocity

CMEA Capital is trying its hand at virtual development with newco Velocity Pharmaceutical Development LLC.

Velocity plans to acquire early stage candidates, ensconce each in a company structure without an associated staff, develop them through proof-of-concept data and then sell them. Velocity

Read the full 422 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers